World's Best Scientists 2026 revealed!
Enrico Heffler

Enrico Heffler

D-Index & Metrics

Immunology

D-Index
58
Citations
12563
World Ranking
3513
National Ranking
137

Enrico Heffler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Enrico Heffler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 422 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Enrico Heffler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Enrico Heffler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Enrico Heffler is affiliated with Humanitas University in Italy and has made substantial contributions to medical research, particularly in the fields of physiology, pulmonary and respiratory medicine, immunology and allergy, otorhinolaryngology, and surgery. Their research portfolio includes 554 publications concentrated across these domains, reflecting a broad engagement with topics related to respiratory health and diseases.

The scientist's work focuses extensively on areas such as asthma and respiratory diseases, allergic rhinitis and sensitization, sinusitis and nasal conditions, respiratory and cough-related research, inhalation and respiratory drug delivery, chronic obstructive pulmonary disease (COPD) research, and nasal surgery and airway studies.

Frequent publication venues for their work include:

  • Allergy
  • World Allergy Organization Journal
  • Current Opinion in Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Zenodo (CERN European Organization for Nuclear Research)

Notable recent papers authored or co-authored by Enrico Heffler are:

  • Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial, 2021, Journal of Allergy and Clinical Immunology
  • Eosinophilic and Noneosinophilic Asthma, 2021, CHEST Journal
  • EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023, 2023, Rhinology Journal
  • Biologics and airway remodeling in severe asthma, 2022, Allergy
  • Defining a Severe Asthma Super-Responder: Findings from a Delphi Process, 2021, The Journal of Allergy and Clinical Immunology In Practice

Enrico Heffler frequently collaborates with other researchers. Their most common co-authors include:

  • Giorgio Walter Canonica
  • Giovanni Paoletti
  • Francesca Puggioni
  • Luca Malvezzi
  • Gianenrico Senna

Best Publications

  • EUFOREA consensus on biologics for CRSwNP with or without asthma

    Wytske J. Fokkens;Valerie Lund;Claus Bachert;Claus Bachert;Joaquim Mullol

  • Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.

    Marek L. Kowalski;Ioana Agache;Sevim Bavbek;Arzu Bakirtas

  • Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.

    Eileen Wang;Michael E. Wechsler;Trung N. Tran;Liam G. Heaney

  • Interleukin-5 in the Pathophysiology of Severe Asthma

    Corrado Pelaia;Giovanni Paoletti;Francesca Puggioni;Francesca Racca

  • EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.

    Unknown

  • Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.

    Claus Bachert;Joseph K. Han;Martin Y. Desrosiers;Philippe Gevaert

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.

    Liam G. Heaney;Luis Perez de Llano;Mona Al-Ahmad;Vibeke Backer

  • Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

    François-Xavier Lescure;Hitoshi Honda;Robert A Fowler;Jennifer Sloane Lazar

  • Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs

    Gilda Varricchi;Diego Bagnasco;Francesco Borriello;Enrico Heffler

  • Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma

    Enrico Heffler;Lorena Nascimento Girardi Madeira;Matteo Ferrando;Francesca Puggioni

  • Biologics and airway remodeling in severe asthma

    Unknown

  • Causes of food-induced anaphylaxis in Italian adults: a multi-centre study.

    R. Asero;L. Antonicelli;A. Arena;L. Bommarito

  • Toward clinically applicable biomarkers for asthma: An EAACI position paper.

    Zuzana Diamant;Zuzana Diamant;Susanne Vijverberg;Kjell Alving;Arzu Bakirtas

  • The Severe Asthma Network in Italy: Findings and Perspectives.

    Enrico Heffler;Francesco Blasi;Francesco Blasi;Manuela Latorre;Francesco Menzella

  • EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study.

    R. Asero;L. Antonicelli;A. Arena;L. Bommarito

  • The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

    Giancarlo Marone;Francescopaolo Granata;Valentina Pucino;Antonio Pecoraro

  • Allergy in severe asthma

    S R Del Giacco;A Bakirtas;E Bel;A Custovic

  • Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

    Unknown

  • Defining a Severe Asthma Super-Responder: Findings from a Delphi Process.

    John W. Upham;John W. Upham;Chantal Le Lievre;David J. Jackson;Matthew Masoli

  • Minimal clinically important difference for asthma endpoints: An expert consensus report

    Matteo Bonini;Matteo Bonini;Marcello Di Paolo;Diego Bagnasco;Ilaria Baiardini

  • Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.

    Giorgio Walter Canonica;Giorgio Lorenzo Colombo;Giacomo Matteo Bruno;Sergio Di Matteo

  • Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis

    Enrico Heffler;Francesca Puggioni;Silvia Peveri;Marcello Montagni

  • Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders

    Gilda Varricchi;Diego Bagnasco;Francesco Borriello;Enrico Heffler

Frequent Co-Authors

Giovanni Rolla
Giovanni Rolla University of Turin
Giorgio Walter Canonica
Giorgio Walter Canonica Humanitas University
Francesco Blasi
Francesco Blasi University of Milan
Giovanni Passalacqua
Giovanni Passalacqua University of Genoa
Pierluigi Paggiaro
Pierluigi Paggiaro University of Pisa
Gianenrico Senna
Gianenrico Senna University of Verona
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Claus Bachert
Claus Bachert Karolinska Institute
Liam G. Heaney
Liam G. Heaney Queen's University Belfast
David Price
David Price University of Aberdeen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open doors to diverse healthcare career paths. For example, transitioning to roles like an acute care nurse practitioner becomes accessible through acute care np certification, which equips nurses with specialized skills to manage critically ill patients.

Many professionals accelerate their journey through healthcare by enrolling in an accelerated nurse practitioner program. These programs offer a faster pathway to advanced practice roles, ideal for those aiming to quickly enter the workforce with advanced credentials.

For individuals without a nursing background, there are excellent options like 12-month accelerated nursing programs online for non nurses. These programs provide a rapid and flexible route into nursing, making the transition smoother and more accessible.

Lastly, some prospective students benefit from exploring absn programs with high acceptance rates. These programs increase the chances of admission, helping students begin their nursing education without prolonged delays.

Best Scientists Citing Enrico Heffler

Trending Scientists

Recently Published Articles